节点文献

肝素缓释可降解支架在心肌血运重建中的应用研究

Experimental Study of Heparin-Slow-Release Stent in Myocardial Revascularization after Acute Myocardial Infarction

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 刘月驹张光伟刘晓程史蓉芳刘天军赵晓斌吕丰

【Author】 LIU Yueju,ZHANG Guangwei, LIU Xiaocheng, SHI Rongfang, LIU Tianjun, ZHAO Xiaobin, Lu Feng Chinese Academy of Medical Sciences & Peking Union Medical College & TEDA International Cardiovascular Hospital , Tianjin 300457, China

【机构】 中国医学科学院北京协和医学院泰达国际心血管病医院中国医学科学院北京协和医学院生物医学工程研究所分子设计实验室

【摘要】 目的:探讨肝素缓释支架在急性心肌梗死后心肌血运重建中的作用。方法:通过结扎前降支冠状动脉制作猪急性心肌梗死模型,然后随机分为3组,A组(6只)为对照组,B组(6只)为心肌打孔组,C组(6只)为心肌打孔+支架植入组。在B组和C组中,于心肌梗死区采用自制高速钻孔器由心外膜打2个直径为3.5mm透壁孔道,C组每个孔道内植入1枚肝素缓释支架。分别于治疗前和治疗后6周观察组织学改变、新生血管密度、心肌灌注及心功能变化。结果:治疗后6周,B组孔道完全闭塞,C组孔道仍然开放,内壁被一层内皮细胞覆盖。C组中新生血管密度较A组和B组明显增加(均P<0.001);治疗前后C组灌注质量缺损百分率的差值(△MDP)较A组和B组明显改善(均P<0.001);C组存活心肌面积较A组和B组明显增加(均P<0.01);C组左室射血分数为较A组和B组明显提高(均P<0.05)。结论:肝素缓释支架可以维持穿心肌孔道开放,促进心肌梗死后血管再生,增加心肌灌注,提高心肌存活,改善心功能,可能成为心肌梗死后再血管化的有效方法。

【Abstract】 Objective: To investigate the effect of heparin-slow-release stent implanted into transmural channels on myocardial revascularization after acute myocardial infarction. Methods: The animal models were established by ligation of the mid third of left anterior descending (LAD) in miniswine. Miniswines were divided into control group (A group, n = 6), transmyocardial drilling revascularization (TMDR) group (B group, n = 6) and TMDR+stent implantation group (C group, n = 6). In B and C groups, two transmural channels with 3.5 mm in diameter were established by using a self-made drilling device, followed by implantation of two stents into the channels in C group. The vascular density, myocardial perfusion, histological and morpho-logical analyses, and left ventricular (LV) function were evaluated at pre-treatment and 6 weeks post-treatment. Results: The vascular density was significantly increased after 6 weeks treatment in C group compared with that in A group and B group (P < 0.001). Changes of mass defect percent (△MDP) were significantly decreased in B group compared with that of A group and B group. There were more viable cardiaomyocytes in C group than that in A group(P < 0.001) and B group(P = 0.003). LV ejection fraction (EF) was significantly increased in C group than that of A group(P = 0.037) and B group(P = 0.019). There were no significant differences in these parameters between A group and B group. Conclusion: The heparin-slow-release stent implanted into transmural channel could keep the channel open and promote luminal endothelialization by continuous anticoagulation, which promoted angiogenesis, increased myocardial perfusion, enhanced myocardial viability, improved LV function. The heparin-slow-release stent may be a new method for myocardial revascularization of acute myocardial infarction.

【基金】 天津市科技发展计划资助项目(项目编号:05YFGZSF02900)
  • 【文献出处】 天津医药 ,Tianjin Medical Journal , 编辑部邮箱 ,2010年08期
  • 【分类号】R542.22
  • 【被引频次】2
  • 【下载频次】75
节点文献中: 

本文链接的文献网络图示:

本文的引文网络